Talk to Alison
00 1 718 618 48 97
Search inside this page
Publication dates
Publishers
data types
Free Market Research Guides to Download
» Purchase Premium Reports
61-100 of about 700 reports
Yearly, From 2003 To 2011
By Business Monitor International
Source: BMI Espicom
Yearly, From January 01, 2011 To January 01, 2011
By Business Monitor International
Source: BMI Espicom
Yearly, From 2004 To 2011
By Business Monitor International
Source: BMI Espicom
Yearly, From 2003 To 2011
By Business Monitor International
Source: BMI Espicom
Yearly, From 2004 To 2011
By Business Monitor International
Source: BMI Espicom
Yearly, From 2003 To 2011
By Business Monitor International
Source: BMI Espicom
Yearly, From 2003 To 2011
By Business Monitor International
Source: BMI Espicom
Yearly, From 2004 To 2011
By Business Monitor International
Source: BMI Espicom
Yearly, From January 01, 2011 To January 01, 2011
By Business Monitor International
Source: BMI Espicom
Yearly, From 2004 To 2011
By Business Monitor International
Source: BMI Espicom
This new report from Venture Planning Group provides an overview of the Italian coagulation testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test ...
This new 243-page report from Venture Planning Group presents a detailed analysis of the ß-2 Microglobulin testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical ...
This new 278-page report from Venture Planning Group presents a detailed analysis of the CA 15-3/27.29, CA 19-9, and CA 125 testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, ...
This new 250-page report from Venture Planning Group presents a detailed analysis of the CEA testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance ...
This new 242-page report from Venture Planning Group presents a detailed analysis of the PAP testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance ...
This new 243-page report from Venture Planning Group presents a detailed analysis of the Occult Blood testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical ...
This new 243-page report from Venture Planning Group presents a detailed analysis of the Pap Smear/HPV testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical ...
This new 249-page report from Venture Planning Group presents a detailed analysis of the PSA testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance ...
This new 288-page report from Venture Planning Group presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views ...
This new 200-page report from Venture Planning Group presents a detailed analysis of the E. Coli diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...
This new 23-page report from Venture Planning Group provides an overview of the Italian infectious disease diagnostics market, including market shares of leading suppliers by test, as well as volume and ...
This new 288-page report from Venture Planning Group presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views ...
This new 205-page report from Venture Planning Group presents a detailed analysis of the Adenovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...
This new 200-page report from Venture Planning Group presents a detailed analysis of the Aeromonads diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...
This new 220-page report from Venture Planning Group presents a detailed analysis of the Chancroid diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...
This new 230-page report from Venture Planning Group presents a detailed analysis of the Campylobacter diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...
This new 184-page report from Venture Planning Group presents a detailed analysis of the Chlamydia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...
This new 225-page report from Venture Planning Group presents a detailed analysis of the Clostridium diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...
This new 231-page report from Venture Planning Group presents a detailed analysis of the Cytomegalovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...
This new 190-page report from Venture Planning Group presents a detailed analysis of the Coxsackievirus diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...
This new 207-page report from Venture Planning Group presents a detailed analysis of the Cryptosporidium diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...
This new 191-page report from Venture Planning Group presents a detailed analysis of the Cyclospora diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...
This new 200-page report from Venture Planning Group presents a detailed analysis of the E. Coli diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...
This new 193-page report from Venture Planning Group presents a detailed analysis of the Echovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...
This new 202-page report from Venture Planning Group presents a detailed analysis of the Enterovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...
This new 205-page report from Venture Planning Group presents a detailed analysis of the Gonorrhea diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...
This new 320-page report from Venture Planning Group presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...
This new 241-page report from Venture Planning Group presents a detailed analysis of the Herpes diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...
This new 208-page report from Venture Planning Group presents a detailed analysis of the Helicobacter Pylori diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current ...
This new 232-page report from Venture Planning Group presents a detailed analysis of the Influenza diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...
» Download Public Reports
23 reports
... Is primarily engaged in the design, manufacture and marketing of high performance diagnostic imaging systems for medical and dental applications in its medical systems group. Through its milan, italy based ...
» Read our Company Profiles
24 CompaniesReportlinker.com © Copyright 2013. All rights reserved.